Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors

NCT07505069 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: RT01-89Zr

Sponsor

Nanolattix Biotechnology Co., Ltd.